Vascular symptoms in patients with primary Raynaud's phenomenon are not exacerbated by propranolol or labetalol.

This publication has 13 references indexed in Scilit:

• Raynaud's Disease: Reduced Hand Blood Flows with Normal Blood Viscosity
  Australian and New Zealand Journal of Medicine, 1978
• RESPONSES OF THE CARDIOVASCULAR SYSTEM OF THE RAT TO NORADRENALINE INFUSIONS AND THEIR MODIFICATION BY ADRENOCEPTOR BLOCKING AGENTS
  British Journal of Pharmacology, 1977
• Raynaud's phenomenon as side effect of beta-blockers in hypertension.
  BMJ, 1976
• Beta Adrenergic Dilator Component of the Sympathetic Vascular Response in Skeletal Muscle Influence on the micro‐circulation and on transcapillary exchange
  Acta Physiologica Scandinavica, 1976
• The mechanisms of Raynaud's phenomenon: Part 1.
  1974
• Haemodynamic Changes in Long-Term Therapy of Essential Hypertension: A Comparative Study of Diuretics, α-Methyldopa and Clonidine
  Clinical Science, 1973
• Pharmacology of AH 5158; a drug which blocks both α‐ and β‐adrenoceptors
  British Journal of Pharmacology, 1972
• Propranolol in hypertension: A study of long-term therapy, 1964–1970
  American Heart Journal, 1972
• The Effects of Intra‐arterially Administered Propranolol¹and H 56/28²on Blood Flow in the Forearm—a Comparative Study of Two ß‐adrenergic Receptor Antagonists
  Acta Pharmacologica et Toxicologica, 1967
• Effects of propranolol on peripheral vessels in man
  The American Journal of Cardiology, 1966